Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2015

View Archived Issues

Ferring acquires assets of orthopedic biomaterial developer BioSET

Propanc starts animal studies of proteolytic proenzymes for cancer

RepliCel Life Sciences submits clinical trial application for RCS-01

ZP-GA-1 shows similar PK characteristics to native glucagon

Marathon sells non-strategic products to focus on treatments for rare diseases

Merck Serono and Sysmex Inostics announce opening of liquid biopsy RAS biomarker testing center

Cyclenium Pharma and Fundacion Medina form drug discovery agreement

Xeris Pharmaceuticals presents comparative PK/PD study of G-Pump and GlucaGen

Plasma kallikrein inhibitors disclosed in Kalvista Pharmaceuticals patent

U. S. researchers develop recombinant N. meningitidis factor H binding proteins

Isis reports chemically modified ssASOs targeting ataxin-3

Galapagos patents CFTR modulators

Takeda patent reveals prokineticin PKR1 receptor antagonists

New orexin receptor antagonists disclosed by Merck & Co.

Saroglitazar reverses biochemical manifestations of metabolic syndrome

Nobelpharma launches Zanosar i.v. infusion in Japan

Axitinib shows activity against mutant BCR-ABL1 leukemia

Eisai's phase III trial of eribulin in soft tissue sarcoma meets primary endpoint

AstraZeneca and Orca Pharmaceuticals partner to discover ROR gamma inhibitors

Isis Pharmaceuticals announces phase I results for prekallikrein inhibitor for HAE

Phase I results indicate ALKS-7106 does not warrant further development

Neurotrope releases topline results from phase IIa trial of bryostatin 1 for Alzheimer's disease

First patient treated in trial of Renevia in HIV-associated lipoatrophy

Eisai reports results from phase II trial of lenvatinib in NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...